| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.04 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |